Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care.

Chih S, McDonald M, Dipchand A, Kim D, Ducharme A, Kaan A, Abbey S, Toma M, Anderson K, Davey R, Mielniczuk L, Campbell P, Zieroth S, Bourgault C, Badiwala M, Clarke B, Belanger E, Carrier M, Conway J, Doucette K, Giannetti N, Isaac D, MacArthur R, Senechal M.

Can J Cardiol. 2020 Mar;36(3):335-356. doi: 10.1016/j.cjca.2019.12.025.

PMID:
32145863
2.

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.

Fine NM, Davis MK, Anderson K, Delgado DH, Giraldeau G, Kitchlu A, Massie R, Narayan J, Swiggum E, Venner CP, Ducharme A, Galant NJ, Hahn C, Howlett JG, Mielniczuk L, Parent MC, Reece D, Royal V, Toma M, Virani SA, Zieroth S.

Can J Cardiol. 2020 Mar;36(3):322-334. doi: 10.1016/j.cjca.2019.12.034.

PMID:
32145862
3.

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.

O'Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D'Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B.

Can J Cardiol. 2020 Feb;36(2):159-169. doi: 10.1016/j.cjca.2019.11.036.

PMID:
32036861
4.

Hyperkalemia in heart failure.

Sidhu K, Sanjanwala R, Zieroth S.

Curr Opin Cardiol. 2020 Mar;35(2):150-155. doi: 10.1097/HCO.0000000000000709.

5.

The Hospital Frailty Risk Score and its association with in-hospital mortality, cost, length of stay and discharge location in patients with heart failure short running title: Frailty and outcomes in heart failure.

Kwok CS, Zieroth S, Van Spall HGC, Helliwell T, Clarson L, Mohamed M, Mallen C, Duckett S, Mamas MA.

Int J Cardiol. 2020 Feb 1;300:184-190. doi: 10.1016/j.ijcard.2019.09.064. Epub 2019 Oct 9.

PMID:
31699454
6.

Relation of Increasing QRS Duration Over Time and Cardiovascular Events in Outpatients With Heart Failure.

Alfraidi H, Seifer CM, Hiebert BM, Torbiak L, Zieroth S, McIntyre WF.

Am J Cardiol. 2019 Dec 15;124(12):1907-1911. doi: 10.1016/j.amjcard.2019.09.018. Epub 2019 Sep 26.

PMID:
31668343
7.

The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review.

Dyck GJB, Raj P, Zieroth S, Dyck JRB, Ezekowitz JA.

Int J Mol Sci. 2019 Feb 19;20(4). pii: E904. doi: 10.3390/ijms20040904. Review.

8.

Comparative effectiveness of the different components of care provided in heart failure clinics-protocol for a systematic review and network meta-analysis.

Slater M, Bielecki J, Alba AC, Abrahamyan L, Tomlinson G, Mak S, MacIver J, Zieroth S, Lee D, Wong W, Krahn M, Ross H, Rac VE.

Syst Rev. 2019 Feb 2;8(1):40. doi: 10.1186/s13643-019-0953-4.

9.

Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent? 1.

Louis XL, Raj P, Chan L, Zieroth S, Netticadan T, Wigle JT.

Can J Physiol Pharmacol. 2019 Jun;97(6):503-514. doi: 10.1139/cjpp-2018-0544. Epub 2018 Dec 21. Review.

PMID:
30576226
10.

Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE-HF study.

Virani SA, Sharma V, McCann M, Koehler J, Tsang B, Zieroth S.

ESC Heart Fail. 2018 Oct;5(5):809-817. doi: 10.1002/ehf2.12309. Epub 2018 Jun 22.

11.

The Need for Heart Failure Advocacy in Canada.

Virani SA, Bains M, Code J, Ducharme A, Harkness K, Howlett JG, Ross H, Sussex B, Zieroth S; Board and Membership of the Canadian Heart Failure Society.

Can J Cardiol. 2017 Nov;33(11):1450-1454. doi: 10.1016/j.cjca.2017.08.024. Epub 2017 Sep 11. No abstract available.

PMID:
29111108
12.

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.

Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth S, Al-Hesayen A, Cohen-Solal A, D'Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B.

Can J Cardiol. 2017 Nov;33(11):1342-1433. doi: 10.1016/j.cjca.2017.08.022. Epub 2017 Sep 6.

PMID:
29111106
13.

Primary Percutaneous Coronary Intervention As Treatment for ST-Elevation Myocardial Infarction in a Centenarian: Choosing Carefully.

Cloutier JM, Zieroth S, Elbarouni B.

Can J Cardiol. 2017 Aug;33(8):1066.e1-1066.e3. doi: 10.1016/j.cjca.2017.05.002. Epub 2017 May 8.

PMID:
28673761
14.

Barriers to Goals of Care Discussions With Patients Who Have Advanced Heart Failure: Results of a Multicenter Survey of Hospital-Based Cardiology Clinicians.

You JJ, Aleksova N, Ducharme A, MacIver J, Mielniczuk L, Fowler RA, Demers C, Clarke B, Parent MC, Toma M, Strachan PH, Farand P, Isaac D, Zieroth S, Swinton M, Jiang X, Day AG, Heyland DK, Ross HJ.

J Card Fail. 2017 Nov;23(11):786-793. doi: 10.1016/j.cardfail.2017.06.003. Epub 2017 Jun 23.

PMID:
28648852
15.

Peripartum Cardiomyopathy Characteristics and Outcomes in Canadian Aboriginal and Non-Aboriginal Women.

Liu S, Zuberi SA, Malik AA, Hiebert BM, Schaffer A, Zieroth S, Cordova FJ.

Can J Cardiol. 2017 Apr;33(4):471-477. doi: 10.1016/j.cjca.2016.11.001. Epub 2016 Nov 11.

PMID:
28169090
16.

Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada.

Clarke B, Ducharme A, Giannetti N, Kim D, McDonald M, Pflugfelder P, Rajda M, Sénéchal M, Stadnick E, Toma M, Zieroth S, Isaac D.

J Heart Lung Transplant. 2017 May;36(5):491-498. doi: 10.1016/j.healun.2017.01.003. Epub 2017 Jan 6.

PMID:
28162932
17.

End of life decisions in heart failure: to turn off the intracardiac device or not?

Ayach B, Malik A, Seifer C, Zieroth S.

Curr Opin Cardiol. 2017 Mar;32(2):224-228. doi: 10.1097/HCO.0000000000000366. Review.

PMID:
28079553
18.

Diagnosis of Left Ventricular Assist Device Outflow Graft Obstruction Using Intravascular Ultrasound.

Muller Moran HR, Kass M, Ravandi A, Zieroth S, Schaffer SA, Cordova FJ, Pozeg ZI, Arora RC, Singal RK.

Circ Heart Fail. 2016 Dec;9(12). pii: e003472. No abstract available.

PMID:
27864303
19.

Caregiver experiences of providing care to adult individuals living with a left ventricular assist device: a qualitative systematic review protocol.

Avery LJ, Szwajcer A, Zieroth S, Temple B, Sawatzky JA.

JBI Database System Rev Implement Rep. 2016 Jan;14(1):44-54. doi: 10.11124/jbisrir-2016-2534. No abstract available.

PMID:
26878919
20.

Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.

Raj P, Aloud BM, Louis XL, Yu L, Zieroth S, Netticadan T.

J Nutr Biochem. 2016 Feb;28:155-63. doi: 10.1016/j.jnutbio.2015.09.025. Epub 2015 Oct 19.

PMID:
26878793

Supplemental Content

Loading ...
Support Center